Metoclopramide Injection

Dual effects, both antiemetic and motility-promoting
Rapid onset, direct action
High-purity preparation, reliable safety
Diverse applicable scenarios, extensive clinical needs

Description

Metoclopramide Injection is a dopamine receptor antagonist, with metoclopramide as the main component. It exerts a strong antiemetic effect by blocking dopamine receptors in the central chemoreceptor trigger zone; at the same time, it can promote the peristalsis of gastrointestinal smooth muscles, accelerate gastric emptying, coordinate the movement of the stomach and duodenum, and improve gastrointestinal function.

Its main applicable scenarios include:

Antiemetic treatment: Used for acute nausea and vomiting caused by cancer chemotherapy, post-operation, radiotherapy, migraine, etc.; it can also relieve nausea and vomiting caused by uremia, drugs, infections, etc.

Gastrointestinal motility regulation: Used for delayed gastric emptying, gastroesophageal reflux disease, etc., to relieve dyspeptic symptoms such as bloating, belching, and acid regurgitation; it can also be used before examinations such as gastroscopy and biliary angiography to promote the emptying of gastric contents and facilitate the smooth progress of the examination.

This product is usually administered by intramuscular injection or intravenous injection. The specific dosage needs to be adjusted according to the patient's age, weight and the severity of symptoms. It should generally be used under the guidance of a doctor. After injection, it takes effect quickly, and the antiemetic effect can be quickly manifested.